跳至主要内容
临床试验/ISRCTN42633050
ISRCTN42633050已完成不适用

Clinical and histologic effect of transrectal intraprostatic injections with botulinum toxin A in patients with lower urinary tract symptoms caused by benign prostatic hyperplasia

niversity Medical Center Utrecht (UMCU) (The Netherlands)0 个研究点目标入组 20 人开始时间: 2006年11月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age more than 55
  • 2. Signed informed consent
  • 3. Lower Urinary Tract Symptoms (LUTS) with International Prostatic Symptom Score (IPSS) more than seven
  • 4. Insufficient response to oral medication
  • 5. Prostatic volume 30 to 50 ml
  • 6. Urodynamic infravesical obstruction more than grade II according to Schafer
  • 7. Willing and able to fill out questionnaires and voiding diaries
  • 8. Willing and able to attend proposed investigations

排除标准

  • 1. Neuropathic bladder dysfunction
  • 2. Prostatic carcinoma
  • 3. Coagulation disorder
  • 4. Urinary tract infection
  • 5. Bladder calculus
  • 6. Post-renal renal insufficiency
  • 7. Myopathic disorder
  • 8. Anatomical defects preventing transrectal approach

研究者

发起方
niversity Medical Center Utrecht (UMCU) (The Netherlands)

相似试验